{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:35:46Z","timestamp":1794335746538,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013221","name":"Razi Vaccine and Serum Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013221","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.biologicals.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T16:17:55Z","timestamp":1555777075000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6\/CFP-10 recombinant protein"],"prefix":"10.1016","volume":"59","author":[{"given":"Mozhdeh","family":"Namvarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Tebianian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mahmoud","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Kashkooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.04.002_bib1","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2015"},{"issue":"6","key":"10.1016\/j.biologicals.2019.04.002_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijid.2005.04.001","article-title":"Current issues in global tuberculosis control. International journal of infectious diseases","volume":"9","author":"Frothingham","year":"2005","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0307-299","article-title":"Changing funding patterns in tuberculosis","volume":"13","author":"Kaufmann","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.biologicals.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41479-016-0020-z","article-title":"Novel vaccination approaches to prevent tuberculosis in children","volume":"8","author":"Triccas","year":"2016","journal-title":"Pneumonia (Nathan)."},{"issue":"4","key":"10.1016\/j.biologicals.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.coi.2006.05.016","article-title":"Progress in tuberculosis vaccine development","volume":"18","author":"Baumann","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.biologicals.2019.04.002_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prrv.2010.09.013","article-title":"Prospects for a new, safer and more effective TB vaccine","volume":"12","author":"Hawkridge","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2051013615593891","article-title":"Recent advances in the development of vaccines for tuberculosis","volume":"3","author":"Ahsan","year":"2015","journal-title":"Ther Adv Vaccines"},{"issue":"9","key":"10.1016\/j.biologicals.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2006.11.014","article-title":"Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens","volume":"25","author":"Sable","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.04.002_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxicon.2015.10.003","article-title":"Mechanism of ESAT-6 membrane interaction and its roles in pathogenesis of Mycobacterium tuberculosis","volume":"116","author":"Peng","year":"2016","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.biologicals.2019.04.002_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect Immun"},{"issue":"9633","key":"10.1016\/j.biologicals.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation","volume":"372","author":"Hoft","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biologicals.2019.04.002_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"10.1016\/j.biologicals.2019.04.002_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1461-5347(00)00281-9","article-title":"Intranasal vaccines: forthcoming challenges","volume":"3","author":"Partidos","year":"2000","journal-title":"Pharmaceut Sci Technol Today"},{"issue":"6","key":"10.1016\/j.biologicals.2019.04.002_bib14","first-page":"729","article-title":"Advantages of intranasal vaccination and considerations on device selection","volume":"71","author":"Birkhoff","year":"2009","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.biologicals.2019.04.002_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","article-title":"Strategies for intranasal delivery of vaccines","volume":"3","author":"Zaman","year":"2013","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/toxins7030974","article-title":"Cholera toxin B: one subunit with many pharmaceutical applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines3030579","article-title":"Cholera toxin subunit B as adjuvant--an accelerator in protective immunity and a break in autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.biologicals.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/mi.2016.95","article-title":"Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon. Mucosal immunology","volume":"10","author":"Baldauf","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"10","key":"10.1016\/j.biologicals.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/infdis\/jiw160","article-title":"Antigen-independent restriction of pneumococcal density by mucosal adjuvant cholera toxin subunit B","volume":"214","author":"Kuipers","year":"2016","journal-title":"J Infect Dis"},{"issue":"29","key":"10.1016\/j.biologicals.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.biologicals.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1128\/JVI.00339-16","article-title":"Effects of MF59 adjuvant on induction of isotype-switched IgG antibodies and protection after immunization with T-dependent influenza virus vaccine in the absence of CD4+ T cells","volume":"90","author":"Ko","year":"2016","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.biologicals.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.153.9.4029","article-title":"Systemic cytokine profiles in BALB\/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants","volume":"153","author":"Valensi","year":"1994","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.biologicals.2019.04.002_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0264-410X(95)00089-J","article-title":"Enhancement of humoral response against human influenza vaccine with the simple submicron oil\/water emulsion adjuvant MF59","volume":"13","author":"Ott","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biologicals.2011.02.002","article-title":"Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70","volume":"39","author":"Tebianian","year":"2011","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.biologicals.2019.04.002_bib26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1586\/14760584.7.9.1341","article-title":"Is intranasal vaccination a feasible solution for tuberculosis?","volume":"7","author":"Giri","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.biologicals.2019.04.002_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-3083.2002.01049.x","article-title":"Development of mixed Th1\/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCG","volume":"55","author":"Lagranderie","year":"2002","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.biologicals.2019.04.002_bib28","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/IAI.68.7.3854-3860.2000","article-title":"Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment","volume":"68","author":"Tanghe","year":"2000","journal-title":"Infect Immun"},{"issue":"24","key":"10.1016\/j.biologicals.2019.04.002_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7748\/ns2008.02.22.24.35.c6413","article-title":"Intramuscular injection techniques","volume":"22","author":"Hunter","year":"2008","journal-title":"Nurs Stand"},{"issue":"7762","key":"10.1016\/j.biologicals.2019.04.002_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(72)90926-9","article-title":"Uptake of IgG after intramuscular and subcutaneous injection","volume":"1","author":"Smith","year":"1972","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.biologicals.2019.04.002_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7748\/ns.29.38.61.s43","article-title":"Subcutaneous injection","volume":"29","author":"Smith","year":"2015","journal-title":"Nurs Stand"},{"issue":"50","key":"10.1016\/j.biologicals.2019.04.002_bib32","first-page":"32","article-title":"Subcutaneous injection","volume":"100","author":"Higgins","year":"2004","journal-title":"Nurs Times"},{"issue":"1","key":"10.1016\/j.biologicals.2019.04.002_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.biologicals.2019.04.002_bib34","first-page":"443","article-title":"Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice","volume":"22","author":"Zhang","year":"2006","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.biologicals.2019.04.002_bib35","first-page":"205","article-title":"Quantiation of IL-4, IL-10 and IFN-\u03b3 genes expression after immunization of mice with CFP-10 and ESAT-6 containing vectors","volume":"10","author":"Torabi","year":"2013","journal-title":"Iran J Immunol"},{"issue":"1","key":"10.1016\/j.biologicals.2019.04.002_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","article-title":"A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice","volume":"62","author":"Li","year":"2014","journal-title":"Molr immunol"},{"issue":"12","key":"10.1016\/j.biologicals.2019.04.002_bib37","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.00793-08","article-title":"Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria","volume":"76","author":"Ciabattini","year":"2008","journal-title":"Infect Immun"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618300861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618300861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:06Z","timestamp":1760922846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618300861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":37,"alternative-id":["S1045105618300861"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.04.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6\/CFP-10 recombinant protein","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}